4 курс / Дерматовенерология / Хламидийно_ассоциированные_инфекции_Хворик_Д_Ф_

Use of CpG Oligodeoxynucleotides as an Adjuvant Induces a Protective Immune Response against an Intranasal Chlamydial Challenge / R.A. Hawkins, R.G. Rank, K.A. Kelly // Infect. Immun. – 2002. – Vol. 70, № 9. – P. 4812–4817.

291.Head-to-head evaluation of five chlamydia tests relative to a quality-assured culture standard / W.J. Newhall [et al.] // J. Clin. Microbiol. –1999. – Vol. 37, № 3. – P. 681–685.

292.Henry-Suchet, J. Clinical consequences of immune response to CT upper genital tract infection in women / J. HenrySuchet, M. Askienazy-Elbhar, J. Orfila // Infect. Dis. Obstet. Gynecol. – 1996. – Vol. 4, № 3. – P. 171–175.

293.Herold, A.H. Seasonality of Chlamydia trachomatis genital infections in university women / A.H. Herold, L.J. Woodard, R.G. Roetzheim // J. Am. Coll. Health. – 1993. – Vol. 42, № 3. – P. 117–120.

294.Host immune response in chlamydial cervicitis / P. Misukiewicz [et al.] // Inter. Conf. STD : abstr. Book, Yokogama, Japan, 1994. – Yokogama, 1994. – Vol. l. – P. 142.

295.Hwang, L. Chlamydia trachomatis infection in adolescents / L. Hwang, M.A. Shafer // Adv. Pediatr. – 2004. – Vol. 51.

– P. 379–407.

296.Identification of 2 Chlamydia trachomatis antigens recognized by synovial fluid T cells from patients with Chlamydia induced reactive arthritis / J.S. Gaston [et al.] // J. Rheumatol.

– 1996. – Vol. 23, № 1. – P. 130–136.

297.Identification of T cells that respond toserovarspecific regions of the Chlamydia trachomatis major outer membrane protein in persons with serovar E infection / J.N. Arno [et al.] // J. Infect. Dis. – 1998. – Vol. 178, № 6. – P. 1713–1718.

298.IgG subclass-specific antibodies in Chlamydia pneumonia infections / T. Anttila [et al.] // Scand. J. Infect. Dis. – 1998. – Vol. 30, № 4. – P. 381–386.

299.Igietseme, J.U. Role for CD8+T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones / J.U. Igietseme [et al.] // Infect. Immun. – 1994. – Vol. 62, № 11.

– P. 5195–5197.

300.IL-10 gene knockout mice show enhanced Thl – like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection / X. Yang [et al.] // J. Immunol. – 1999. – Vol. 162, № 2. – P. 1010–1017.

311

301.IL-10 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis / S. Kotake [et al.] // J. Clin. Invest. – 1999. – Vol. 103, № 9. – P. 1345–1352.

302.Immune responses to Chlamydial antigens in humans

// L. Hanna [et al.] // Med. Microbiol. Immunol. – 1982. – Vol. 171, № 1. – P. 1-10.

303.Immunization with the Chlamydia trachomatis Mouse Pneumonitis Major Outer Membrane Protein by Use of CpG Oligodeoxynucleotides as an Adjuvant Induces a Protective Immune Response against an Intranasal Chlamydial Challenge / S. Pal [et al.] // Infect. Immun. – 2002. – Vol. 70, № 9. – P. 4812–4817.

304.Induction of antibody response in mice by different way of introduction of inactivated C. trachomatis MT-2A strain with polyoxidonium combination / L.V. Rubanik [et al.] // Proceeding sixth meeting of the European Society for Chlamydia research (Aarhus, Denmark, July 1-4, 2008). – Aarhus, 2008. – P. 285.

305.Induction of HLA class I-restricted CD8 (+) CTLs specific for the major outer membrane protein of Chlamydia trachomatis in human genital tract infections / S.K. Kim [et al.] // J. Immunol. – 1999. – Vol. 162, № 11. – P. 6855–6866.

306.Interference of Staphylococcus aureus in the detection of Chlamydia trachomatis by monoclonal antibodies / Т. Krech [et al.] // Lancet. – 1985. – Vol. № 8438. – P. 1161–1162.

307.Internalization of Chlamydia by dendritic cells and stimulation of Chlamydia-specific T cells / D.M. Ojcius [et al.] // J. Immunol. – 1998. – Vol. 160, № 3. – P. 1297–1303.

308.Jain, S. Perinatally acquired Chlamydia trachomatis associated morbidity in young infants / S. Jain // J. Matern. Fetal. Med. – 1999. – Vol. 8, № 3. – Р. 130–133.

309.Jones, R.B. Prevalence in Chlamydia trachomatis of heterotypic tetracycline resistance and lack of association with short-term treatment failures / R.B. Jones, В. Van der Pol, В. Katz // J. Infect. Dis. – 1993. – Vol. 1698, № 6. – P. 1406–1407.

310.Kelly, K.A. Cellular immunity and Chlamydia genital infection: induction, recruitment, and effectors mechanisms / K.A. Kelly // Int. Rev. Immunol. – 2003. – Vol. 22, № 1.

– P. 3–41`.

311.Kol, A. Chlamydial heart shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor

312

alpha and matrix metalloproteinase expression / A. Kol, A.M. Sukhova, A.M. Lichtman // Circulation. – 1998. – Vol. 98. – Р. 300–307.

312.Kutlin, A. Antibody response to Chlamydia pneumonias infection in children with respiratory illness / A. Kutlin, P.M. Roblin, M.R. Hammerschtag // J. Infect. Dis. – 1998. – Vol. 177,

№3. – P. 720–724.

313.Laboratory diagnosis of sexually transmitted infections in Estonia in 2001-2002: shortcomings with impact on diagnostic quality and surveillance / P. Naaber [et al.] // Sex. Transm. Dis. – 2005. – Vol. 32, № 12. – P. 759–764.

314.Laboratory diagnostics for non-viral sexually transmitted infections in St. Petersburg, Russia: current situation and hallmarks for improvements / M. Domeika [et al.] // J. Acad. Dermatol. Venereol. – 2008. – Apr. 9. – [Epub ahead of print].

315.Latency in human infections with TRIC agents / L. Hanna [et al.] // J. Immunol. – 1968. – Vol. 101, № 1. – P. 43–50.

316.Lau, C.Y. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials / C.Y. Lau, A.K. Qureshi // Sex. Transm. Dis. – 2002. – Vol. 29, № 9. – P. 497–502.

317.Leonardo, C. Women and sexually transmitted diseases / C. Leonardo, J.C. Chrisler // Women Health. – 1992. – Vol. 18, № 4. – P. 1–15.

318.Levine, W.C. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases / W.C. Levine, V. Pope, P. Tambe // J. Infect. Dis. – 1999. – Vol. 17. – P. 167–174.

319.Long-term eradication of chlamydia trachomatis genital infection after antimicrobial therapy / K. Workowski [et.al.] // JAMA. – 1993. – Vol. 270, № 17. – P. 2071–2075.

320.Loomis, W.P. T cell responses to Chlamydia trachomatis / W.P. Loomis, M.N. Starnbach // Curr. opin. Microbiol. – 2002. – Vol. 5, № 1. – P. 87–91.

321.Mabey, D.C. Immunology of chlamydial infections / D. Mabey // In Pros. Meet. Eur. Soc. Chlam. Res. – Helsinki, 2000. – P. 157–160.

322.Management of chronic prostatitis in Genitourinary Medicine clinics in the United Kingdom's North Thames Region 2000 / A. Dale [et. al.] // Int. J. STD AIDS. – 2001. – Vol.12, №

313

4.– P. 256–259.

323.Mark, K. Clinical implications of dysregulated cytokine production / K. Mark, J. Slifka, W. Lindsay // J. Molecular Medicine. – 2000. – Vol. 78. – P. 74–80.

324.Meacci, F. Chlamydia trachomatis specific immunoparameters and cytokine production in semen from males affected by prostatitis / F. Meacci, A. Salvi, S. Mazzoli // Infect. Dis. Obstet. Gynecol. – 1996. – Vol. 4, № 3. – P. 199–200.

325.Morrison, R.P. Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of gamma interferon / R.P. Morrison // Infect. Immun. – 2000. – Vol. 68, №

10.– P. 6038–6040.

326.Morrе, S.A. Maurine models of Chlamydia trachomatis genital tract infection: use of mouse pneumonitis strain versus human strains / S.A. Morrе, J.M. Lyons // Infect. Immun. – 2000.

– Vol. 68, № 12. – P. 7209–7211.

327.Morton, R.C. Chlamydial Infection: an overview. Is it time for a wider /broader hypothesis / R.C. Morton // International handbook of Chlamydia / ed. T.R. Moss. – N.Y. : Polestar Wheatons Ltd, 2001. – P. 153–161.

328.Moulder, J.W. Persistent infection of mouse fibroblasts (L cells) with Chlamydia psittaci: evidence for a cryptic chlamydial form / J.W. Moulder, N.J. Levy, R.P. Schulman // Infect. Immun. – 1980. – Vol. 30, № 3. – P. 874–883.

329.Multiple drug resistant Chlamydia trachomatis associated with clinical treatment failure / J. Somani [et. al.] // J. Infect. Dis. – 2000. – Vol. 181, № 4. – P. 1421–1427.

330.Myziuk, L. Endocervical Gram stain smears and their usefulness in the diagnosis of Chlamydia trachomatis / L. Myziuk, B. Romanowski, M. Brown // Sex. Transm. Infect. – 2001. – Vol. 77, № 2. – P. 103–106.

331.National laboratory reports of Chlamydia trachomatis seriously underestimate the frequency of genital chlamydial infections among women in Switzerland / W.J. Paget [et al.] // Sex. Transm. Dis. – 2002. – Vol. 29, № 11. – P. 7l5–720.

332.Nelson, H.D. Screening for chlamydial infection / H.D. Nelson, M. Helfand // Am. J. Prev. Med. – 2001. – Vol. 20, № 3, suppl. – P. 95–107.

333.Nicond, E. Place de Chlamydia trachomatis dans la pathologic urogenitale masculine: aspect epidemiologique et

314

diagnostique / E. Nicond, Y. Grenn, M. Meyran // Fertil. Biol. – 1994. – Vol. 197. – P. 51–61.

334.Order of urine collection affects in the diagnosis of chlamydia trachomatis infection in men by ligase chain reaction / M.A. Chernesky [et al.] // 11th Meet. Int. Soc. STD Res, New Orleans Aug. 27-30. – New Orleans, 1995. – P. 180.

335.Paavonen, J. Chlamydia trachomatis and cancer / J. Paavonen // Sex. Transm. Infect. – 2001. – Vol. 77, № 3. – P. 154–156.

336.Pearce, J.H. Chlamydial Infection / J.H. Pearce, I. Allan. – N.Y. : Elsevier, 1982. – P. 29.

337.Peeling, R.W. A guide for diagnostic evaluations / R.W. Peeling, P.G.Smith, P.M. Bossuyt // Nat. Rev. Microbiol. – 2006. – Vol. 4, № 12, suppl. – P. 52–56.

338.Performance of transcription-mediated amplification and ligase chain reaction assays for detection of chlamydial infection in urogenital samples obtained by invasive and noninvasive methods / A. Stary [et al.] // J. Clin. Microbiol. – 1998. – Vol. 36, № 9. – P. 2666–2670.

339.Perry, L.L. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-γ-dependent and independent pathways / L.L. Perry, K. Feilzer, H.D. Caldwell // J. Imltnol. – 1997. – Vol. 158, № 7. – P. 3344–3352.

340.Persistence of Chlamydia trachomatis serovar К in a

non-culturable but metabolically active state in human peripheral blood monocytes / L. Koehler [et al.] // Proc. 3th Meet. Eur. Soc. Chlam. Res., Vienna, Austria, 11-14 Sept 1996. – Vienna, 1996. – P. 331.

341.Persson, K. The role of serology, antibiotic susceptibility testing and serovar determination in genital chlamydial infections / K. Persson // Best. Pract. Res. Clin. Obstet Gynaecol. – 2002. – Vol. 16, № 6. – P. 801–814.

342.Phylogenic analyses of the coding genes the new chlamydial taxonomy / K.D.E. Everett [et al.] // 4th European Chlamydia Congress «Chlamydia 2000». Abstract book. – Helsinki, 2000. – P. 42.

343.Post-therapeutic evolution of serum chlamydial antibody titers in women with acute salpingitis and tubal infertility / J. Henry-Suchet [et al.] // Fertil. Steril. – 1994. – Vol. 62, № 2. – P. 296–304.

315

344.Prediction of MYCN amplification in neuroblastoma using serum DNA and Real-time quantitative Polymerase Chain Reaction / T. Gotoh [et al.] // J. Clin. Oncol. – 2005. – Vol. 23, №

22.– Р. 5205–5210.

345.Protective efficacy of distinct lymphocyte subsets in

skid mice infected with the mouse pneumonitis agent of Chlamydia trachomatis / S. Thoma-Uszynski [et al.] // Proc. 3 th Meet. Eur. Soc. Chiam. Res., Vienna, Austria, 11-14 Sept., 1996. – Vienna, 1996. – P. 70.

346.Provision of chlamydia testing in a nationwide service offering termination of pregnancy: with data capture to monitor prevalence of infection / H. Mallinson [et al.] // Sex. Transm. Infect. – 2002. – Vol. 78, № 6. – P. 416–421.

347.Quantitative Chlamydia trachomatis cultures: corre-

lation of chlamydial inclusion forming units with serovar' age, sex' and race / L.O. Eckert [et al.] // J. Infect. Dis. – 2000. – Vol. 182, № 2. – P. 540–544.

348.Rank, R.G. Animal models for ocular infections / R.G. Rank, J.A. Whittum Hudson // Methods Enzymol. – 1994. – №

235.– P. 69–83.

349.Real-time quantitative PCR for human herpes virus 6 DNA / G. Locatelli [et al.] // J. Clin. Microbiol. – 2000. – Vol. 38, № 1. – Р. 4042–4048.

350.Ridgway, G.L. Antibiotic Management of Chlamydial Genital Infections / G.L. Ridgway // Proc. Workshop «Human Chlamydial Infections», Izmir, Turkey. – Izmir, 1997. – P. 38-44.

351.Risk factors For Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya / J. Kimani [et al.] // J. Infect. Dis. – 1996. – Vol. 173, № 6. – P. 1473–1474.

352.Saikku, P. Chlamydia pneumonia and heart disease / P. Saikku // Internationalhandbook of Chlamydia / ed. T.R. Moss. – N.Y. : Polestar Wheatons Ltd, 2001. – P. 131–139.

353.Savitcheva, A.M. Obstetrical aspects of genital chlamydiosis / A.M. Savitcheva, E. Ailamazyan // Proc. Workshop «Human Chlamydial Infections», Izmir, Turkey. – Izmir, 1997. – P. 97.

354.Schachter, J. Infection and disease epidemiology / J. Schachter // Chlamydia: intracellular biology, pathogenesis, and immunity. – Washington : ASM Press, 1999. – P. 139–169.

316

355.Schachter, J. Prospective study of perinatal transmission of Chlamydia trachomatis / J. Schachter // JAMA. – 1986. – Vol. 255, № 24. – P. 3374–3377.

356.Semenov, D.M., The frequency of Chlamydia trachomatis, Micoplasma hominy’s, Ureaplasma urealyticum in

women with inflammatory diseases of uterus appendages / D.M. Semenov // 10th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Stockholm, Sweden. 2000. – Stockholm, 2000. – P. 147-148.

357.Serum Immunoglobulin G Antibodies to Chlamydial Heat Shock Protein 60 but Not to Human and Bacterial Homolog’s Are Associated With Coronary Artery Disease. / O.S. Mahdi [et al.] // Circulation. – 2002. – Vol. 106, № 13. – Р. 1659– 1663.

358.Sexually Transmitted Diseases Diagnostics Initiative. Evaluation of rapid diagnostic tests: chlamydia and gonorrhea / A.Herring [et al.] // Nat. Rev. Microbiol. – 2006. – Vol. 4, № 12, suppl. – P. 41–48.

359.Stary, A. DNA amplification, antigen detection tests,

and culture: which sample for which technique / A. Stary // Proc. 3th Meet. Eur. Soc. Chlam. Res., Vienna, Austria, 11-14 Sept., 1996. – Vienna, 1996. – P. 251–253.

360.Studies in knockout mice reveal that antichlamydial protection requires Th1 cells producing IFN-gamma: is this true for humans? / M. Johansson [et al.] // Scand. J. Immunol. – 1997.

–Vol. 46, № 6. – P. 546–552.

361.Taylor-Robinson, D. Evolution of enzyme immunoassay (Chlamydiazyme) for detecting Chlamydia trachomatis in genital tract specimens / D. Taylor-Robinson, B.J. Thomas, M.F. Osborn // J. Clin. Pathol. – 1987. – Vol. 40, № 2. – P. 194–197.

362.The potential for vaccine development against chlamydial infection and disease / R.C. Brunham [et al.]// J. Infect. Dis. – 2000. – Vol. 181, suppl. 3. – P. 538–543.

363.The role of spermatozoa in the pathogenesis of Chlamydia trachomatis salpingitis in a primate model / D.L. Patton [et al.] // Sex. Transm. Dis. – 1993. – Vol. 20, № 4. – P. 214–219.

364.Thomas, B.J. Evolution of sensitivity of 10 diagnostic assays for Chlamydia trachomatis by use of simple laboratory procedure / B.J. Thomas, E.J. MacLeod, D. Taylor-Robinson // J. Clin.Pathol. – 1993. – Vol. 46, № 10. – P. 912–914.

317

365.Toomey, K.E. Treatment of Chlamydia trachomatis genital inflectional / K.E. Toomey, R.C. Barnes // Rev. Infection. Dis. – 1990. – Vol. 12, suppl. 6. – P. 645–655.

366.Use of direct fluorescent antibody test for detecting Chlamydia trachomatis cervical infection in women seeking routine gynecological care / R.N. Philip [et al.] // J. Infect. Dis. – 1987. – Vol. 156, № 4. – P. 575–581.

367.Ustacelebi, S. Bacteriology and molecular biology of Chlamydia / S. Ustacelebi // Proc. Workshop «Human Chlamydial Infections», Izmir, Turkey, 1997. – Izmir, 1997. – P. 9–23.

368.Van Bergen, J.E. Increased incidence of gonorrhea and Chlamydia trachomatis infections in family practice in southeast Amsterdam (1996-2000) / J.E. Van Bergen // Ned. Tijdschr. Geneeskd. – 2001. – Vol. 145, № 35. – P. 1691–1693.

369.Weber, J.Т. New treatments for chlamydia trachomatis genital infection / J.Т. Weber, R.E. Johnson // Clin. Infect. Dis. – 1995. – Vol. 20, suppl. 1. – P. 966–971.

370.Westram, L. Consequences of genital Chlamydial infections in women / L. Westram //Proc. 3th Meet. Eur. Soc. Chlam. Res., Vienna, Austria, 11-14 Sept., 1996. – Vienna, 1996.

–P. 137.

318

Приложение

Заболеваемость основными ИППП в Республике Беларусь

2002-2010 гг. (на 100 000 населения)

Заболеваемость урогенитальным трихомониазом в Республике Беларусь в 2010 г.

Заболеваемость генитальным герпесом в Республике Беларусь в 2010 г.

319

Заболеваемость урогенитальным хламидиозом в Республике Беларусь в 2010 г.

Заболеваемость инфекциями, обусловленными ВПЧ, в Республике Беларусь в 2010 г.

Заболеваемость урогенитальным микоплазмозом, обусловленным M.genitalium, в Республике Беларусь в 2010 г.

320